Atlas Trials

29-Gene Liver Cancer Subtype and Immunotherapy Effectiveness

Clinical trial NCT07100236 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07100236
Sponsor
Junjie Xu
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Primary Hepatocellular Carcinoma
Start date
2025-08-01
Primary completion
2027-05-01
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.